tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

GoodRx, others in talks with White House to join TrumpRx, Reuters reports

Retail pharmacies and prescription drug savings site GoodRx (GDRX) are in discussions with the Trump administration about joining its TrumpRx website, indicating an expansion beyond the early description of it as a link to drugmakers’ direct discounts, Reuters’ Deena Beasley reports. Pharma companies, including Pfizer (PFE) and Amgen (AMGN) are offering to sell some brand-name medicines directly to consumers at the negotiated prices they get from insurers, the author says. Some say they plan tot work with TrumpRx, driven in part by President Trump’s threats of harsh tariffs on drugmakers that don’t lower prices and boost U.S. manufacturing, the author says, noting the site is due to launch in 2026. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1